GlassScriptPhysician profile
Richard C Smith
NPI 1801857453
$23,571.74
in general payments reported to CMS, 2019-2025
6 companies · $23K in 2025
The $23K reported for 2025 was more than what 92% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2025: $23K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $23K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $23,214.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $17,142.85 | 2025 | |
| Smith+Nephew, INC. | $6,071.43 | 2025 | |
| Amarin Pharma, INC. | $125.00 | 2019 | |
| Skeletal Dynamics INC | $104.19 | 2019 | |
| Medtronic USA, INC. | $73.63 | 2019 | |
| Conmed Corporation | $54.64 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.